EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Abca7 V1613M variant reduces Aβ generation, plaque load, and neuronal damage

Claire A Butler, Adrian Mendoza Arvilla, Giedre Milinkeviciute, Celia Da Cunha, Shimako Kawauchi, Narges Rezaie, Heidi Y Liang, Dominic Javonillo, Annie Thach, Shuling Wang, Sherilyn Collins, Amber Walker und 11 weitere

Alzheimer's & Dementia · 2024-07 · 20 (7) · 4914-4934

DOI: 10.1002/alz.13783 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 20.03.2024. Verfasst von Claire A Butler und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology and Behavior, University of California, Irvine, California, USA. Hauptthemen laut MEDLINE: ATP-Binding Cassette Transporters, Plaque, Amyloid, Amyloid beta-Peptides, Alzheimer Disease. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, Cancer Center Support, Center for Complex Biological Systems Support.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Variants in ABCA7 , a member of the ABC transporter superfamily, have been associated with increased risk for developing late onset Alzheimer's disease (LOAD). METHODS CRISPR‐Cas9 was used to generate an Abca7 V1613M variant in mice, modeling the homologous human ABCA7 V1599M variant, and extensive characterization was performed. RESULTS Abca7 V1613M microglia show differential gene expression profiles upon lipopolysaccharide challenge and increased phagocytic capacity. Homozygous Abca7 V1613M mice display elevated circulating cholesterol and altered brain lipid composition. When crossed with 5xFAD mice, homozygous Abca7 V1613M mice display fewer Thioflavin S‐positive plaques, decreased amyloid beta (Aβ) peptides, and altered amyloid precursor protein processing and trafficking. They also exhibit reduced Aβ‐associated inflammation, gliosis, and neuronal damage. DISCUSSION Overall, homozygosity for the Abca7 V1613M variant influences phagocytosis, response to inflammation, lipid metabolism, Aβ pathology, and neuronal damage in mice. This variant may confer a gain of function and offer a protective effect against Alzheimer's disease‐related pathology. Highlights ABCA7 recognized as a top 10 risk gene for developing Alzheimer's disease. Loss of function mutations result in increased risk for LOAD. V1613M variant reduces amyloid beta plaque burden in 5xFAD mice. V1613M variant modulates APP processing and trafficking in 5xFAD mice. V1613M variant reduces amyloid beta‐associated damage in 5xFAD mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ATP-Binding Cassette TransportersPlaque, AmyloidAmyloid beta-PeptidesAlzheimer DiseaseMice, TransgenicAnimalsMiceNeuronsDisease Models, AnimalHumansBrainMicrogliaPhagocytosisAmyloid beta-Protein Precursor

Stichwörter der Autor:innen

ABCA7Alzheimer's diseaseAβlipidsneuroinflammation

Substanzen

ATP-Binding Cassette TransportersAmyloid beta-PeptidesABCA7 protein, humanAbca7 protein, mouseAmyloid beta-Protein Precursor

Autor:innen und Institutionen

  • Department of Neurobiology and Behavior, University of California, Irvine, California, USA.
  • Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, California, USA.
  • Transgenic Mouse Facility, ULAR, Office of Research, University of California, Irvine, California, USA.
  • Department of Developmental and Cell Biology, University of California, Irvine, California, USA.
  • Center for Complex Biological Systems, University of California, Irvine, California, USA.
  • Department of Neurology, University of California, Irvine, California, USA.

Förderung

  • NIA NIH HHS
  • Cancer Center Support
  • Center for Complex Biological Systems Support
  • National Institute on Aging

Zitieren

APA

Butler, C. A., Mendoza Arvilla, A., Milinkeviciute, G., Da Cunha, C., Kawauchi, S., Rezaie, N., Liang, H. Y., Javonillo, D., Thach, A., Wang, S., Collins, S., Walker, A., Shi, K. X., Neumann, J., Gomez-Arboledas, A., Henningfield, C. M., Hohsfield, L. A., Mapstone, M., Tenner, A. J., …, & Green, K. N. (2024). The Abca7 V1613M variant reduces Aβ generation, plaque load, and neuronal damage. Alzheimer's & Dementia, 20(7), 4914-4934. https://doi.org/10.1002/alz.13783

Vancouver

Butler CA, Mendoza Arvilla A, Milinkeviciute G, Da Cunha C, Kawauchi S, Rezaie N, et al. The Abca7 V1613M variant reduces Aβ generation, plaque load, and neuronal damage. Alzheimer's & Dementia. 2024;20(7):4914-4934. doi:10.1002/alz.13783

BibTeX
@article{Butler2024,
  author = {Butler, Claire A and Mendoza Arvilla, Adrian and Milinkeviciute, Giedre and Da Cunha, Celia and Kawauchi, Shimako and Rezaie, Narges and Liang, Heidi Y and Javonillo, Dominic and Thach, Annie and Wang, Shuling and Collins, Sherilyn and Walker, Amber and Shi, Kai-Xuan and Neumann, Jonathan and Gomez-Arboledas, Angela and Henningfield, Caden M and Hohsfield, Lindsay A and Mapstone, Mark and Tenner, Andrea J and LaFerla, Frank M and Mortazavi, Ali and MacGregor, Grant R and Green, Kim N},
  title = {The Abca7 V1613M variant reduces Aβ generation, plaque load, and neuronal damage},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  volume = {20},
  number = {7},
  pages = {4914--4934},
  doi = {10.1002/alz.13783}
}
Kostenlos starten →